Fife 'cancer plaster' firm raises cash

Patient wearing Ambulight PDT device The company believes the device could free up hospital beds used in traditional PDT treatment

Related Stories

Medical device firm Ambicare Health is to start rolling out its lead skin cancer treatment product after securing £1.7m in a fund-raising exercise.

The Ambulight PDT is a light-emitting sticking plaster used in photodynamic therapy (PDT) for treating non-melanoma skin cancer.

The wearable device delivers treatment directly to a skin lesion site.

The Fife-based company is a spin-out of Dundee's Ninewells Hospital and St Andrews University.

The funding-raising round was led by Longbow Capital, with additional funds coming from the Scottish Venture Fund, DC Thomson and private individuals.

The company said its lead product could free up hospital beds used in traditional PDT treatment and improve patient care.

Ian Muirhead, chief executive of Ambicare Health, said: "Feedback from dermatologists on the Ambulight PDT has been excellent and indicates that we have a product that will make a real difference in how patients are treated for non-melanoma skin cancer."

More on This Story

Related Stories

The BBC is not responsible for the content of external Internet sites

BBC Edinburgh, Fife and East

Weather

Edinburgh

Min. Night 13 °C

Features & Analysis

Elsewhere on the BBC

Programmes

  • A person taking a photo of fireworks on a smartphoneClick Watch

    A look at the latest gadgets which could make it easier to take the perfect night-time picture

BBC © 2014 The BBC is not responsible for the content of external sites. Read more.

This page is best viewed in an up-to-date web browser with style sheets (CSS) enabled. While you will be able to view the content of this page in your current browser, you will not be able to get the full visual experience. Please consider upgrading your browser software or enabling style sheets (CSS) if you are able to do so.